Advanced Biomed Income Statement (2023-2025) | ADVB

Income Statement Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating items
Research & Development (Quarter) 0.19M0.31M0.21M0.18M0.21M0.25M0.23M0.24M0.19M
Selling, General & Administrative (Quarter) 0.46M0.43M0.50M0.34M0.07M0.51M0.98M0.29M0.21M
Operating Expenses (Quarter) 0.65M0.75M0.70M0.52M0.28M0.76M1.21M0.52M0.40M
EBIT (Quarter) -0.15M-1.06M-0.81M-0.27M-0.58M-1.38M-0.70M-0.39M7.00M
Non-operating items
Non Operating Investment Income (Quarter) 7.35M
Interest & Investment Income (Quarter) 0.02M104.000.03M10.000.02M26.000.01M448.000.01M
Other Non Operating Income (Quarter) 0.49M-0.31M0.25M-0.31M-0.62M0.14M0.04M
Non Operating Income (Quarter) 0.49M-0.31M-0.08M0.25M-0.31M-0.62M0.51M0.14M7.40M
Net income details
EBT (Quarter) -0.15M-1.06M-0.81M-0.27M-0.58M-1.38M-0.70M-0.39M7.00M
Profit After Tax (Quarter) -0.15M-1.06M-0.81M-0.27M-0.91M-1.38M-0.70M-0.39M6.86M
Income from Continuing Operations (Quarter) -0.15M-1.06M-0.81M-0.27M-0.58M-1.38M-0.70M-0.39M7.00M
Consolidated Net Income (Quarter) -0.15M-1.06M-0.81M-0.27M-0.33M-1.38M-0.70M-0.39M-0.14M
Income towards Parent Company (Quarter) -0.15M-1.06M-0.81M-0.27M-0.33M-1.38M-0.70M-0.39M-0.14M
Net Income towards Common Stockholders (Quarter) -0.15M-1.06M-0.81M-0.27M-0.33M-1.38M-0.70M-0.39M-0.14M
Additional items
EPS (Basic) (Quarter) -0.01-0.05-0.04-0.01-0.03-0.07-0.03-0.020.32
EPS (Weighted Average and Diluted) (Quarter) -0.01-0.05-0.04-0.01-0.03-0.07-0.03-0.020.31
Shares Outstanding (Weighted Average) (Quarter) 20.00M20.00M20.00M20.00M
Shares Outstanding (Diluted Average) (Quarter) 20.00M20.00M20.00M20.00M
EBITDA (Quarter) -0.61M-0.69M-0.66M-0.57M-0.47M-1.34M-0.65M-0.47M6.48M